Clinical trial
Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Endovascular Thrombectomy on Acute Basilar Artery Occlusion - a Multicenter, Randomized Controlled, Clinical Trial
NCT05827042 is registered in ClinicalTrials.gov with The First Affiliated Hospital of University of Science and Technology of China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Endovascular Thrombectomy on Acute Basilar Artery Occlusion - a Multicenter, Randomized Controlled, Clinical Trial
- Lead sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 9, 2023
- Completion date
- April 7, 2026
- Enrollment
- 338 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute cerebrovascular accident, basilar artery occlusion, stroke due to basilar artery occlusion